CytomX Therapeutics (CTMX) Interest Expenses (2014 - 2017)
CytomX Therapeutics' Interest Expenses came in at $206,000 for Q1 2017, down 41.6% from $353,000 a year earlier and down 47.0% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Interest Expenses (2014 - 2017) Analysis & Trends
Over the trailing twelve months to Mar 31, 2017, CytomX Therapeutics reported Interest Expenses of $1.54 million, down 16.9% year-over-year; for FY2016, it was $1.69 million, down 2.5% from FY2015.
- Interest Expenses carries a three-year compound annual growth rate of 88.0% (FY2013 to FY2016).
- Going back by year, Interest Expenses was $1.73 million in FY2015 (+255.6%), $487,000 in FY2014 (+91.7%) and $254,000 in FY2013.
- The Q1 2017 figure represents the lowest quarterly Interest Expenses since Q4 2014.
- Year-over-year, Interest Expenses increased in five of the last seven quarters, with growth averaging 107.9%.
- Business Quant data shows CTMX's Interest Expenses at $389,000 (Q4 2016), $482,000 (Q3 2016) and $465,000 (Q2 2016) in the three quarters before Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | CytomX Therapeutics | 434.93 Mn | -727.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 206,000.00 |
| Dec 31, 2016 | 389,000.00 |
| Sep 30, 2016 | 482,000.00 |
| Jun 30, 2016 | 465,000.00 |
| Mar 31, 2016 | 353,000.00 |
| Dec 31, 2015 | 376,000.00 |
| Sep 30, 2015 | 718,000.00 |
| Jun 30, 2015 | 408,000.00 |
| Mar 31, 2015 | 230,000.00 |
| Dec 31, 2014 | 109,000.00 |
| Sep 30, 2014 | 117,000.00 |
API Access
CytomX Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();